Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer

PURPOSE: Oral capecitabine has been used as adjuvant therapy for colorectal cancer patients since the 1990s. Patient-initiated cessation or reduced use of capecitabine occurs widely for various reasons, yet the consequences of these actions are unclear. The present study sought to clarify treatment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yun, Jung-A, Kim, Hee Cheol, Son, Hyun-Sook, Kim, Hyoung Ran, Yun, Hae Ran, Cho, Yong Beom, Yun, Seong Hyeon, Lee, Woo Yong, Chun, Ho-Kyung
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Korean Society of Coloproctology 2010
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2998011/
https://ncbi.nlm.nih.gov/pubmed/21152231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/jksc.2010.26.4.287
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge